Updated on 16 October 2026
HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseases
Director at Interagens s.r.l.
Rome, Italy
About
We offer our expertise in AI and gamification to help "develop more innovative, safer and more effective therapeutic solutions" using a "multidisciplinary approach (e.g. lifestyle changes, cognitive training, rehabilitation therapies) [which] should lead to an improved quality of life and reduce the societal impact of these diseases."
Topic
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
Jérémie THIBLET
Chief Growth Officer at Neoventures Biotechnology Europe
Villejuif, France
Project cooperation
Innovative technologies in pediatric rehabilitation
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
- Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Fabio Alexander Storm
Researcher at IRCCS E. MEDEA - Associazione La Nostra Famiglia
Bosisio Parini, Italy
Project cooperation
AI-powered Clinical Intelligence and Healthcare Interoperability for personalised Care
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
Marco Crimi
Founder & Director at Net Medicare
Bergamo, Italy